Brief: Mynd Analytics & Emmaus Life Sciences Announce Joint Proxy Statement Relating To Merger & Spin-Off
12/06/2019 17:51
June 12 (Reuters) - MYnd Analytics Inc MYND.O :
* MYND ANALYTICS AND EMMAUS LIFE SCIENCES ANNOUNCE
AVAILABILITY OF
DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS RELATING TO MERGER
AND SPIN-OFF TRANSACTION
Source text for Eikon: ID:nGNXbM27zh
Further company coverage: MYND.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns